» Articles » PMID: 15364936

Recognition of Phosphodegron Motifs in Human Cyclin E by the SCF(Fbw7) Ubiquitin Ligase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Sep 15
PMID 15364936
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Turnover of cyclin E is controlled by SCF(Fbw7). Three isoforms of Fbw7 are produced by alternative splicing. Whereas Fbw7alpha and -gamma are nuclear and the beta-isoform is cytoplasmic in 293T cells, all three isoforms induce cyclin E destruction in an in vivo degradation assay. Cyclin E is phosphorylated on Thr(62), Ser(88), Ser(372), Thr(380), and Ser(384) in vivo. To examine the roles of phosphorylation in cyclin E turnover, a series of alanine point mutations in each of these sites were analyzed for Fbw7-driven degradation. As expected, mutation of the previously characterized residue Thr(380) to alanine led to profound defects of cyclin E turnover, and largely abolished association with Fbw7. Mutation of Thr(62) to alanine led to a dramatic reduction in the extent of Thr(380) phosphorylation, suggesting an indirect effect of this mutation on cyclin E turnover. Nevertheless, phosphopeptides centered at Thr(62) associated with Fbw7, and residual binding of cyclin E(T380A) to Fbw7 was abolished upon mutation of Thr(62), suggesting a minor role for this residue in direct association with Fbw7. Mutation of Ser(384) to alanine also rendered cyclin E resistant to degradation by Fbw7, with the largest effects being observed with Fbw7beta. Cyclin E(S384A) associated more weakly with Fbw7alpha and -beta isoforms but was not defective in Thr(380) phosphorylation. Analysis of the localization of cyclin E mutant proteins indicated selective accumulation of cyclin E(S384A) in the nucleus, which may contribute to the inability of cytoplasmic Fbw7beta to promote turnover of this cyclin E mutant protein.

Citing Articles

The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development.

de la Cova C Cells. 2023; 12(17).

PMID: 37681873 PMC: 10486803. DOI: 10.3390/cells12172141.


FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.

Wei W, Qin B, Wen W, Zhang B, Luo H, Wang Y Signal Transduct Target Ther. 2023; 8(1):187.

PMID: 37202390 PMC: 10195794. DOI: 10.1038/s41392-023-01405-8.


DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.

Wang Y, Ju L, Wang G, Qian K, Jin W, Li M Nat Commun. 2023; 14(1):2421.

PMID: 37105989 PMC: 10140023. DOI: 10.1038/s41467-023-38160-x.


Dysregulation of FBW7 in malignant lymphoproliferative disorders.

Wan X, Guo W, Zhan Z, Bai O Front Oncol. 2022; 12:988138.

PMID: 36457505 PMC: 9707496. DOI: 10.3389/fonc.2022.988138.


Counting Degrons: Lessons From Multivalent Substrates for Targeted Protein Degradation.

Okoye C, Rowling P, Itzhaki L, Lindon C Front Physiol. 2022; 13:913063.

PMID: 35860655 PMC: 9289945. DOI: 10.3389/fphys.2022.913063.